Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Trillium Therapeutics Inc. V.SSS

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: T.TR
Alternate Symbol(s):  SCTPD | SCTPF

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.
Price: N/A Volume: 0
Change: N/A % Change: N/A
Day High/Low: N/A/N/A 52 Week High/Low: N/A/N/A
Last Traded: N/A Transaction Volume:
Open: Previous Close:
Bid: Ask:
Bid Size: 0 Ask Size: 0
Market Cap: N/A Shares Out: 6.6m
PE Ratio: N/A Dividend Yield: N/A


Technology that may save lives: Stem Cell Therapeutics

Stock has been fairly range-bound in terms of price since last May   March 16, 2009
0 stars

Latest Bullboard Posts

  • RE:RE:RE:RE:RE:Game Changer....

    0 stars

    I just try and post any info I come across or where to find it. I leave it up too the shareholder, I am not a BUy,BUY or the sky is...

    3 stars

  • RE:RE:RE:RE:Game Changer....

    0 stars

    Thanks JW. I've read that Twitter account and most of the U.S. investors are confused and have to be corrected by Canadian posters. One...

    3 stars

  • RE:RE:RE:Game Changer....

    0 stars

    I am not sure where you get the idea I am saying it is negative? I believe it is very positive. Have a look at the comments on twitter...

    3 stars

  • RE:RE:Game Changer....

    0 stars

    Hello again. Upon further reflection..if you are saying this is a negative gamechanger, I disagree. If I heard the Stanford presentation...

    3 stars

  • Seeking Alpha Article

    0 stars

    A thoughtful report on a small cap healthcare software company for those who are interested:

    2 stars